ImpaCt Of Shiftwork on METabolic Flexibility and Skeletal Muscle Clocks
NCT ID: NCT05820490
Last Updated: 2025-03-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
45 participants
OBSERVATIONAL
2023-07-28
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbreaks in the OR to Mitigate High Physical and Mental Demands
NCT02565394
Reducing Musculoskeletal Stresses and Work-related Injuries Among Allied Health Professionals in Surgical Care
NCT02597959
Comparison of Somatosensory Versus Endurance-strength Exercise in Patients With Chronic Neck Pain
NCT05321537
Pain Modulatory Profiles in Stretching
NCT05891353
Effects Job Rotation in the Prevention of Work Related Musculoskeletal Disorders
NCT01979731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dayshift workers
Whole Room Calorimeter
The indirect calorimetry system allows your oxygen / carbon dioxide exchange to be measured, thereby showing the number of calories burned.
Mixed-Meal Tolerance Test (MMTT)
The MMTT is done to measure how much body handles a mixed meal.This test shake will raise blood sugar and cause the body to produce insulin.
Core Body Temperature
Participants will be asked to swallow a core body temperature monitor prior to entering the whole room calorimeter. This monitor is used to record participants core body temperature.
Morningness-Eveningness Questionnaire
Participants will fill out a questionnaire that asks about your preference for morning or evening.
Muscle Biopsy
Participants will have two skeletal muscle biopsies (one in the evening and one in the morning). This procedure is used to sample muscle cells from the right and left leg Vastus Lateralis (thigh) muscle.
Serial Blood Sampling
Participants will have blood sampled every hour for 24 hours to assess changes in circulating hormones.
Nightshift workers
Whole Room Calorimeter
The indirect calorimetry system allows your oxygen / carbon dioxide exchange to be measured, thereby showing the number of calories burned.
Mixed-Meal Tolerance Test (MMTT)
The MMTT is done to measure how much body handles a mixed meal.This test shake will raise blood sugar and cause the body to produce insulin.
Core Body Temperature
Participants will be asked to swallow a core body temperature monitor prior to entering the whole room calorimeter. This monitor is used to record participants core body temperature.
Morningness-Eveningness Questionnaire
Participants will fill out a questionnaire that asks about your preference for morning or evening.
Muscle Biopsy
Participants will have two skeletal muscle biopsies (one in the evening and one in the morning). This procedure is used to sample muscle cells from the right and left leg Vastus Lateralis (thigh) muscle.
Serial Blood Sampling
Participants will have blood sampled every hour for 24 hours to assess changes in circulating hormones.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whole Room Calorimeter
The indirect calorimetry system allows your oxygen / carbon dioxide exchange to be measured, thereby showing the number of calories burned.
Mixed-Meal Tolerance Test (MMTT)
The MMTT is done to measure how much body handles a mixed meal.This test shake will raise blood sugar and cause the body to produce insulin.
Core Body Temperature
Participants will be asked to swallow a core body temperature monitor prior to entering the whole room calorimeter. This monitor is used to record participants core body temperature.
Morningness-Eveningness Questionnaire
Participants will fill out a questionnaire that asks about your preference for morning or evening.
Muscle Biopsy
Participants will have two skeletal muscle biopsies (one in the evening and one in the morning). This procedure is used to sample muscle cells from the right and left leg Vastus Lateralis (thigh) muscle.
Serial Blood Sampling
Participants will have blood sampled every hour for 24 hours to assess changes in circulating hormones.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Employed as a healthcare worker in either dayshift (N=15) or nightshift work (N=30).
* Nightshift is defined as 12 months of consecutive nightshift work, who had 10 or more nightshifts per month (6 h between 10 PM and 8 AM, with no shift duration \> 12 h).
* Dayshift is defined as 12 months of consecutive dayshift work, who had 10 or more dayshifts per month (6h between 8 AM and 10 PM, with no shift duration \> 12 h).
* Weight Stable (+/- 3 kg over past 6 months)
* BMI between 18.5-29.9 kg/m2
* Understands the procedures and agrees to participate by giving written informed consent
* Willing and able to comply with scheduled visits, laboratory tests, and other study procedures including
* Only low to moderate caffeine users (\<500 mg/day, or up to approximately 5 cups \[1 cup=8 ounces\] of coffee/day.
Exclusion Criteria
* History or presence of cardiovascular disease (unstable angina, myocardial infarction or coronary revascularization within 6 months, presence of cardiac pacemaker, implanted cardiac defibrillator)
* Type 1 or Type 2 diabetes mellitus
* Obesity (BMI ≥ 30 kg/m2)
* Bleeding and clotting disorders
* Uncontrolled hypertension (BP \>160 mmHg systolic or \>100 mmHg diastolic)
* Acute or chronic infections (such as TB, HIV, or Hepatitis)
* Renal insufficiency or nephritis (eGFR\<60), nephritis, or chronic kidney disease
* Chronic obstructive pulmonary disease
* Thyroid dysfunction (suppressed TSH, elevated TSH \<10 µIU/ml if symptomatic or elevated TSH \>10 µIU/ml if asymptomatic)
* Liver disease (liver function tests \> 2 x normal; including nonalcoholic steatohepatitis \[NASH\] and non-alcoholic fatty liver disease \[NAFLD\])
* Diagnosed or being treated for sleep disorders
* History of Cushing's disease or syndrome
* Pregnant or nursing females or females less than 6 months postpartum from the scheduled date of collection
* Anemia (hemoglobin \<12 g/dl in men, \<11 g/dl in women) during screening
* Participation in studies involving investigational drug(s) within 30 days prior to Screening
* Gastrointestinal disorders (including inflammatory bowel disease or malabsorption, swallowing disorders, suspected or known strictures, fistulas or physiological/mechanical GI obstruction, history of gastrointestinal surgery, Crohn's disease or diverticulitis)
* Past or present history of psychiatric disease, including major depressive illness or bipolar disorder, as well as claustrophobia since part of the protocol will involve being confined to a small room for whole-body indirect calorimetry
* Unwilling or unable to eat foods provided in study procedures
* Nickel allergy
* Lidocaine allergy
* Any malignancy not considered cured, except basal cell carcinoma and squamous cell carcinoma of the skin (a participant is considered cured if there has been no evidence of cancer recurrence in the previous 5 years)
* Use of antibiotics within 3 months of screening
* Illicit drug use (negative tests at screening)
* Regular smoking or regular nicotine use of any kind including chewing tobacco, snuff and vaping
* History of regular alcohol consumption exceeding 7 drinks/week for female participants or 14 drinks/week for male participants (1 drink = 5 ounces \[150 mL\] of wine or 12 ounces \[360 mL\] of beer or 1.5 ounces \[45 mL\] of hard liquor) within 6 months before screening.
* Excessive caffeine use (\>500 mg/day, or exceeding 5 cups \[1 cup= 8 ounces\] of coffee/day)
* Blood donation (excluding plasma donations) of approximately 1 pint (500 mL) or more within 56 days prior to Screening (participants may not donate blood any time during the study, through the final study day)
* Presence of any condition that, in the opinion of the Investigator, compromises participant safety or data integrity or the participant's ability to complete study days.
* More than 1-day a week of intentional exercise
Excluded medications include, but are not limited to:
* Any prescription medication or other drug that may influence metabolism (e.g. diet/weight-loss medication, psychiatric medications, corticosteroids, or other medications at the discretion of the PI and/or study team)
* Medications that strongly impact bleeding, clotting, bruising, or platelets (e.g. blood thinner prescription medications)
* Recent change to medication and/or dosing in the past 3 months
* Chronic use of aspirin or other non-steroidal anti-inflammatory drugs, including COX-2 inhibitors
21 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AdventHealth Translational Research Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melissa Erickson, PhD
Role: PRINCIPAL_INVESTIGATOR
Study Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AdventHealth Translational Research Institute
Orlando, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
AdventHealth Translational Research Institute website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1993997
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.